Medical Device lead generation that finds decision-makers.
BeReach reads the public signals medical device companies leave behind, like funding rounds, FDA clearances, product launches and hiring. It qualifies each company against your ICP, then helps you reach the right decision-maker with a warm, contextual message.
1,000+ teams4.9| # | Name | Conn | Signal |
|---|---|---|---|
| 1 |  Elena Petrova VP Regulatory Affairs · Cordell Medical | 2nd | Liked the post |
| 2 |  Brandon Cole Director of Quality · NovaStent | 2nd | Commented |
| 3 |  Yuki Tanabe Head of Clinical Affairs · Aerovance | 3rd | Commented |
| 4 | Marco Bianchi Founder · Lumo Diagnostics | 2nd | Reposted |
| 5 | Diana Popescu Ops Manager · Kestrel Surgical | 3rd | Liked the post |
Medical device signals
funding, clearances, launches, hiring
Typical acceptance rate
warm, contextual first touch
Typical reply rate
vs generic cold outreach
To a qualified list
any class, any stage
Your agent scans where device makers leave a trail: 510(k), De Novo and PMA entries in public registries, funding rounds, new devices and expanded indications, and regulatory, quality and commercial job posts.
Every manufacturer is scored against your ideal profile on device class, clearance recency, funding stage and hiring, so pre-submission teams and companies already shipping are kept apart.
For each qualified manufacturer the agent finds the right regulatory, quality or commercial lead and helps you send a message tied to a real event, like the clearance they just received, not a generic template.
An FDA 510(k), De Novo or PMA clearance means a device is heading to market and the team is standing up commercial and quality operations. Reach them while budgets and priorities are forming.
Know exactly when a device company raises, who led it, and how much. A freshly funded team is actively buying tools, services and partners while the budget is fresh.
New devices and expanded indications signal a company in motion. Lead with a reason tied to what they just brought to market, not a cold pitch.
A manufacturer posting regulatory, quality or commercial roles is scaling toward launch and beyond. Track hiring to find teams in active growth mode.
Prefer to work in Claude?
BeReach runs as a connector inside Claude and Claude Cowork. Ask in plain language and it prospects, qualifies, and drafts your outreach, with every send waiting for your approval. See the Claude connector.
BeReach reads the public web in real time, across funding data, FDA clearance registries, product announcements, job boards and public profiles, then cross-references them to surface qualified companies along with the actual decision-maker's name and how to reach them. It is live signal, not a quarterly database dump.
Legacy databases index enterprise firmographics and refresh slowly, so early device startups and niche manufacturers are under-covered or missing entirely. BeReach searches the real-time sources where device companies actually surface, like funding, FDA clearances, launches and hiring, so it finds accounts those databases do not have.
Yes. Every lead is built from public signals across the open web, including public regulatory registries, cross-referenced and verified. There is no scraping behind a login and no private database, and targeting is B2B, focused on business decision-makers.
Funding stage and recency, FDA clearance status and class, product launches and indications, headcount and hiring activity. You describe your ICP in plain language and the agent scores each company against it, so only the strong-fit ones reach you.
Yes, and that is the difference from a list tool. After the Finder surfaces companies and the Qualifier scores them, the Reacher helps you open a warm, multichannel conversation with the right person, referencing a real signal like a recent clearance or a new raise instead of a generic template.
Yes. Just describe what you want, like a device startup with a recent 510(k) clearance hiring a VP of Regulatory in the US, and the agent handles the combination of class, clearance, role and buying signals. No filters or boolean syntax to learn.
Usually under two minutes. Describe the companies you want, the agent scans the public sources, qualifies them against your ICP, and returns a list with named decision-makers ready to reach out to.
Companies doing LinkedIn ABM well generate $10+ in pipeline per dollar spent and 44% higher ROAS than Google. But most ABM on LinkedIn fails because teams treat it like targeted cold outreach. Here's what the data shows actually works.
Alexandre Sarfati
A fintech founder went from 100 generic DMs per week with zero closed deals to 20 targeted messages and 6 demos in a month. The difference wasn't better copywriting - it was signal-based selling. Here's how the approach works and what the benchmarks look like.
Alexandre Sarfati
A LinkedIn connection request note gives you 300 characters. Here is what the acceptance data says about using them, when to send a blank request instead, and six templates that fit the limit.
Alexandre Sarfati
Describe your ideal device account and let your agent find, qualify, and reach the decision-makers behind it.
Free credits inside · no credit card
Click a button and let your favorite AI weigh in.
